• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2000 Fiscal Year Final Research Report Summary

Analyses of myocardial epitopes and apoptosis with treatment of peptide therapy in myocarditis.

Research Project

Project/Area Number 09470164
Research Category

Grant-in-Aid for Scientific Research (B).

Allocation TypeSingle-year Grants
Section一般
Research Field Circulatory organs internal medicine
Research InstitutionKYOTO UNIVERSITY (1998-2000)
Toyama Medical and Pharmaceutical University (1997)

Principal Investigator

KISHIMOTO Chiharu  Kyoto Univ, Dept.of Cardiovasc.Med, Med.Instructor, 医学研究科, 助手 (70169845)

Co-Investigator(Kenkyū-buntansha) YASUTOMI Yasuhiro  Mie Univ, Dept. of Biological Reg, Professor, Associate Professor, 医学部, 助教授 (90281724)
KURIBAYASHI Kagemasa  Mie Univ, Dept.of Biological Reg, Professor, 医学部, 教授 (10064578)
OCHIAI Hiroshi  Toyama Med.Pharm.Univ.Human Sci. Fund. Nursing, Professor, 医学部, 教授 (30018692)
YOSHIDA Imanaka-kyoko (今中 恭子)  Mie Univ, Dept. of Pathology, Instructor, 医学部, 講師 (00242967)
Project Period (FY) 1997 – 2000
KeywordsViral myocarditis / Dilated cardiomyopathy / Coxsackievirus B3 / Apoptosis / Epitopes / Peptide therapy
Research Abstract

To clarify the pathogenesis and the development of coxsackievirus B3 (CVB3) myocarditis, we examined the histopathology of CVB3-inoculated wild type and severe combined immunodeficient C3H/He mice, and analyzed using subcloning method the sequence of nucleotides of an amyocarditic strain of CVB3 (CVBO) with comparison of that of a myocarditic strain of CVB3 (CVBM), which was already reported. Severe myocarditis developed in wild mice inoculated with CVBM.On the contrary, mild myocarditis resulted from wild mice inoculated with CVBO.In scid mice, severe myocarditis developed by the inoculation of both CVBM and CVBO.There were seven nucleotide differences with five corresponding amino acid changes in the sequence of CVBO in comparison with that of CVBM.The changes located in 1A, 1C, and 1D regions of viral genome, which encoded the envelope protein. Thus, antigenic determinant of CVB3 is related, at least in part, to the recognition of immunocompetent cells to the difference of nucleotides in these regions. In conclusion, the development of myocarditis is related to the immunological background of the host, and myocarditis is due, in part, to an immunopathogenic phenomenon.

  • Research Products

    (20 results)

All Other

All Publications (20 results)

  • [Publications] Kishimoto C,Shioji K,Nakamura H,Nakayama Y,Yodoi J,Sasayama S: "Serum thioredoxin levells in patients with heart failure"Jpn Circ J. (in press). (2000)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Kishimoto C,Takamatsu N,Kawamata H,Shinohara H,Ochiai H: "Immunoglobulin treatment ameliorates murine myocarditis associates with reduction of neurohumoral activity and improvement of extracellular matrix change"J Am Coll Cardiol. 36. 1979-1984 (2000)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Shioji K,Kishimoto C,Nakamura H,Toyokuni S,Nakayama Y,Yodoi J,Sasayama S: "Upregulation of thioredoxin (TRX) expression in giant cell myocarditis in rats"FEBS Letters. 472. 109-113 (2000)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Kishimoto C,Takada H,Hiraoka Y,Shinohara H,Kitagawa M: "Protection against murine coxsakievirus B3 myocarditis by T cell vaccination"J Moll Cell Cardiol. 32. 0-9 (2000)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Shioji K,Kishimoto C,Nakayama Y,Sasayama S: "Strain difference in rats with experimental giant cell myocarditis"Jpn Circ J. 64. 283-286 (2000)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Kishimoto C,Kawamata H,Sakai S,Shinohara H,Ochiai H: "Enhanced production of macrophage inflammatory protein (MIP-2) by in vitro and in vivo infecions with encephalomyocarditis virus and modulation of myocarditis with an antibody against MIP-2"J Virol. 75. 1254-1300 (2000)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 岸本千晴: "臨床免疫"自己免疫性心筋炎とコクサッキーウイルス. 403-408 (2000)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 塩路圭介,岸本千晴,篠山重威: "呼吸と循環"心筋炎に対する免疫グロプリン療法. 1133-1139 (2000)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Takada H, Kishimoto C, Kurokawa M, Shiraki K: "Sasayama S : Captopril suppresses interstitial fibrin diposition in coxsakievirus B3 myocarditis."Am J Physiol. 272. 211-219 (1997)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Kishimoto C, Kitazawa M, Hiraoka Y, Takada H: "Extracellular matrix remodeling in coxsackievirus B3 myocarditis."Clin Immunol & Immunopathol. 85. 47-55 (1997)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Kishimoto C, Kuroki Y, Kurokawa M, Ochiai H: "Lymphokine activated killer cells in murine coxsackievirus B3 myocarditis."Basic Res Cardiol. 92. 4022-4029 (1997)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Kishimoto C, Kitazawa M, Hiraoka Y, Takada H: "Interstitial fibrin-fibronectin deposition with T cell infiltrates precedes fibrosis in murine viral myocarditis."Int J Exp Pathol. 79. 417-423 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Kishimoto C: "Intravenous IgG : Supertherapy for myocarditis and acute dilated cardiomyopathy."Circulation. 99. 975-976 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Kishimoto C, Kawamata H, Sakai S, Shinohara H, Ochiai H: "Role of MIP-2 in coxsackievirus B3 myocarditis."J Mol Cell Cardiol. 32. 631-638 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Kishimoto C, Takamatsu N, Kawamata H, Shinohara H, Ochiai H: "Immunoglobulin treatment ameliorates murine myocarditis associates with reduction of neurohumoral activity and improvement of extracellular matrix change."J Am Coll Cardiol. 36. 1979-1984 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Kishimoto C, Takada H, Hiraoka Y, Shinohara H, Kitagawa M: "Protection against murine coxsackievirus B3 myocarditis by T cell vaccination."J Moil Cell Cardiol. 32. 2269-2277 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Shioji K, Kishimoto C, Nakamura H, Toyokuni S, Nakayama Y, Yodoi J, Sasayama S: "Upregulation of thioredoxin (TRX) expression in giant cell myocarditis in rats."FEBS Letters. 472. 109-113 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Kishimoto C, Kawamata H, Sakai S, Shinohara H, Ochiai H: "Enhanced production of macrophagc inflammatory protein (MIP-2) by in vitro and in vivo infections with encephalomyocarditis virus and modulation of myocarditis with an antibody against MIP-2."J Virol. 75. 1294-1300 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Kishimoto C, Shioji K, Nakamura H, Nakayama Y, Yodoi J, Sasayama S: "Serum thioredoxin (TRX) levels in patient with heart failure."Jpn Circ J. (in press). (2001)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Kishimoto C, Hiraoka Y, Takada H: "T cell mediated immune response enhances the severity of myocarditis in secondary cardiotropic virus infection in mice."Basic Res Cardiol. (in press). (2001)

    • Description
      「研究成果報告書概要(欧文)」より

URL: 

Published: 2002-03-26  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi